Pharmaceutical Approval Update

P T. 2018 Aug;43(8):461-462.

Abstract

Lofexidine hydrocholoride (Lucemyra) for opioid withdrawal; erenumab-aooe (Aimovig) for migraine; and sodium zirconium cyclosilicate (Lokelma) for hyperkalemia.